- World rank, all time
- #28,381 of 34,923
- Rank in United States
- #5,953 of 7,310
- Research works
- 152 ▼ 27% vs 2018-21
- Citations
- 3.3k 21.8 per fractional work
- Top-10% rate
- 12.6% all institutions 10.0%
- vs its own fields
- 1.05× 1.00× is exactly expected
- Open access
- 47% world 40%
- International
- 20% world 18%
Which fields of science does Sage Therapeutics (United States) work in?
In 2022-now, 46% of research at Sage Therapeutics (United States) is in Life Sciences, 40% in Health Sciences. Its largest fields are Medicine (37%), Neuroscience (28%), Biochemistry, Genetics and Molecular Biology (15%). It does 2.7× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 19 fields, with their numbers
- Life Sciences2345.9%
- Health Sciences2040.3%
- Medicine1937.3%
- Health Professions12.7%
- Nursing00.3%
- Social Sciences59.7%
- Psychology36.7%
- Social Sciences11.5%
- Economics, Econometrics and Finance00.8%
- Decision Sciences00.7%
- Physical Sciences24.1%
- Computer Science11.8%
- Mathematics11.1%
- Chemistry00.4%
- Engineering00.3%
- Materials Science00.3%
- Energy00.2%
- Environmental Science00.0%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 17.0×. Every wedge is a field page.
All 18 fields, with their numbers
- Neuroscience17.02×14 works
- Biochemistry, Genetics and Molecular Biology2.83×8 works
- Pharmacology, Toxicology and Pharmaceutics2.51×0 works
- Psychology2.18×3 works
- Immunology and Microbiology2.05×1 works
- Medicine1.94×19 works
- Health Professions1.02×1 works
- Mathematics0.91×0 works
- Decision Sciences0.73×0 works
- Nursing0.59×0 works
- Economics, Econometrics and Finance0.38×0 works
- Chemistry0.25×0 works
- Energy0.24×0 works
- Computer Science0.23×1 works
- Social Sciences0.12×1 works
- Materials Science0.08×0 works
- Agricultural and Biological Sciences0.06×0 works
- Engineering0.02×0 works
- Neuroscience 17.0×
- Biochemistry, Genetics and Molecular Biology 2.8×
- Pharmacology, Toxicology and Pharmaceutics 2.5×
- Psychology 2.2×
- Immunology and Microbiology 2.0×
- Medicine 1.9×
- Health Professions 1.0×
- Mathematics 0.9×
- Decision Sciences 0.7×
- Nursing 0.6×
- Economics, Econometrics and Finance 0.4×
- Chemistry 0.2×
- Energy 0.2×
- Computer Science 0.2×
- Social Sciences 0.1×
- Materials Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.0×
Who are the top researchers at Sage Therapeutics (United States)?
Ranked on the quality score, James Doherty, Michael C. Quirk and Ethan C. Hoffmann lead among researchers whose main affiliation is Sage Therapeutics (United States).
- 1
James Doherty
United States · #263,315 worldwide 5.1k citations · 91 works
- 2
Michael C. Quirk
United States · #291,911 worldwide 5.3k citations · 59 works
- 3
Ethan C. Hoffmann
United States · #312,323 worldwide 2.9k citations · 59 works
- 4
Rebecca Hammond
United States · #312,437 worldwide 4.6k citations · 60 works
- 5
Stephen Kanes
United States · #530,417 worldwide 6.4k citations · 112 works
- 6
Abdul J. Sankoh
United States · #561,202 worldwide 6.3k citations · 63 works
- 7
Robert A. Lasser
United States · #1,052,916 worldwide 6.6k citations · 130 works
- 8
Jeffrey Wald
United States · #1,121,254 worldwide 905 citations · 21 works
- 9
Michael Lewis
United States · #1,220,124 worldwide 658 citations · 41 works
- 10
Margaret E. Gerbasi
United States · #1,403,781 worldwide 1.1k citations · 50 works
Which keywords describe research at Sage Therapeutics (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Mitochondrial Dysfunction, Protein Aggregation, Huntington's Disease, Polyglutamine, Depression, Neurological Disorders, Synaptic Plasticity and Treatment-Resistant Depression.
- Psychological Interventions
- Health Outcomes
- Toxicology
- Cell Signaling
- Schizophrenia
- Dopaminergic Neurons
- Meta-Analysis
- Biomarkers
- Diagnostic Criteria
- Metabolism
- GABAergic
- NMDA Receptor
- Basal Ganglia
- Epilepsy
- Alzheimer's Disease
- Parkinson's Disease
- Treatment-Resistant Depression
- Neurological Disorders
- Protein Aggregation
- Huntington's Disease
- Mitochondrial Dysfunction
- Polyglutamine
- Depression
- Synaptic Plasticity
- Cognitive Impairment
- Oxidative Stress
- Neurodegeneration
- Neurobiology
- Dendritic Spines
- Antidepressant
- Ketamine
- Neurotransmission
- Pharmacology
- Deep Brain Stimulation
- Subthalamic Nucleus
- Prefrontal Cortex
- a-Synuclein
- Neuroimaging
- Crystal Structure
- Hippocampus
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Mitochondrial Dysfunction8▲ 56×3 topics
- Huntington's Disease6▲ 412×1 topic
- Polyglutamine6▲ 412×1 topic
- Protein Aggregation6▲ 238×2 topics
- Depression5▲ 12×12 topics
- Neurological Disorders5▲ 18×10 topics
- Synaptic Plasticity4▲ 38×3 topics
- Treatment-Resistant Depression4▲ 112×2 topics
- Cognitive Impairment3▲ 26×7 topics
- Parkinson's Disease3▲ 26×4 topics
- Oxidative Stress3▲ 3.8×9 topics
- Alzheimer's Disease3▲ 21×5 topics
- Neurodegeneration3▲ 17×4 topics
- Epilepsy2▲ 40×3 topics
- Neurobiology2▲ 17×7 topics
- Basal Ganglia2▲ 75×2 topics
- Dendritic Spines2▲ 54×2 topics
- NMDA Receptor2▲ 104×2 topics
- Antidepressant2▲ 158×1 topic
- GABAergic2▲ 81×1 topic
- Ketamine2▲ 158×1 topic
- Metabolism2▲ 7.3×6 topics
- Neurotransmission2▲ 81×1 topic
- Diagnostic Criteria2▲ 16×4 topics
- Pharmacology2▲ 14×2 topics
- Biomarkers2▲ 4.7×3 topics
- Deep Brain Stimulation2▲ 49×1 topic
- Meta-Analysis2▲ 5.8×7 topics
- Subthalamic Nucleus2▲ 83×1 topic
- Dopaminergic Neurons2▲ 48×1 topic
- Prefrontal Cortex2▲ 36×3 topics
- Schizophrenia2▲ 28×4 topics
- a-Synuclein2▲ 59×1 topic
- Cell Signaling2▲ 19×5 topics
- Neuroimaging2▲ 11×3 topics
- Toxicology2▲ 17×2 topics
- Crystal Structure1▲ 19×2 topics
- Health Outcomes1▲ 9.5×3 topics
- Hippocampus1▲ 40×2 topics
- Psychological Interventions1▲ 19×2 topics
Which research topics does Sage Therapeutics (United States) publish most on?
By volume in 2022-now: Genetic Neurodegenerative Diseases, Treatment of Major Depression, Neuroscience and Neuropharmacology Research and Neurological disorders and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 6 works
- 2 Treatment of Major Depression Pharmacology 2 works
- 3 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 2 works
- 4 Neurological disorders and treatments Neurology 2 works
- 5 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
- 6 Maternal Mental Health During Pregnancy and Postpartum Public Health, Environmental and Occupational Health 1 works
- 7 Dementia and Cognitive Impairment Research Psychiatry and Mental health 1 works
- 8 Cholinesterase and Neurodegenerative Diseases Pharmacology 1 works
- 9 Tryptophan and brain disorders Biological Psychiatry 1 works
- 10 Receptor Mechanisms and Signaling Molecular Biology 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Sage Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 27% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Sage Therapeutics (United States) as a percentage of every work published that year, 0.00020% in 2024.
Fractional works of Sage Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- National Bureau of Economic Research
- World Wide Web Consortium
- Biogen (United States)
- Draper Laboratory
- Cambridge Health Alliance
- Harvard Global Health Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Sage Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
